Works in British Journal of Pharmacology, 2025, Vol 182, Issue 13

Results: 16

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2825, doi. 10.1111/bph.70083

By:

Papapetropoulos, Andreas;
Santo, Evan E.;
Alexander, Stephen P. H.;
Cortese‐Krott, Miriam M.;
Helyes, Zsuzsanna;
Martemyanov, Kirill A.;
Mauro, Claudio;
Panettieri, Reynold A.;
Patel, Hemal H.;
Schulz, Rainer;
Stefanska, Barbara;
Stephens, Gary J.;
Vergnolle, Nathalie;
Wang, Xin;
Ward, Stephen;
Ferdinandy, Péter

Publication type:

Article

Correction to "Ethosuximide: Subunit‐ and Gβγ‐dependent blocker and reporter of allosteric changes in GIRK channels".

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 13, p. 3036, doi. 10.1111/bph.70074
Publication type:: Article

Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2831, doi. 10.1111/bph.70064

By:

Srinivasan, Bharath

Publication type:

Article

Functional MRP1 activity in human skeletal muscle.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2829, doi. 10.1111/bph.70062

By:

Jackwerth, Matthias;
Mairinger, Severin;
Zeitlinger, Markus;
Langer, Oliver

Publication type:

Article

C‐model: A comprehensive enhanced pharmacokinetic/pharmacodynamic simulation environment targeting the complement system.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2842, doi. 10.1111/bph.70054

By:

Alfonso‐González, Lucía;
Vega, M. Cristina;
Fernández, Francisco J.

Publication type:

Article

P2Y14 receptor activation of platelets induces Ca2+ mobilization and Rho‐GTPase‐dependent motility that requires an interaction with P2Y1 receptors.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2950, doi. 10.1111/bph.70024

By:

Hossain, Md Monir;
Pan, Dingxin;
Arkless, Kate L.;
Rahman, Khondaker Miraz;
Page, Clive P.;
Authi, Kalwant S.;
Pitchford, Simon C.

Publication type:

Article

Behavioural and pharmacokinetic analysis of heroin and cocaine self‐administration: Effects of timeout on self‐administration and choice in male rats.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2968, doi. 10.1111/bph.70023

By:

D'Ottavio, Ginevra;
Pezza, Sara;
Modoni, Jacopo;
Reverte, Ingrid;
Marchetti, Claudia;
Zenoni, Soami F.;
De Pirro, Silvana;
Maftei, Daniela;
Lattanzi, Roberta;
Esposito, Giuseppe;
Ragozzino, Davide;
Merlo, Emiliano;
Venniro, Marco;
Ciccocioppo, Roberto;
Fumagalli, Fabio;
Milella, Michele S.;
Badiani, Aldo;
Boix, Fernando;
Caprioli, Daniele

Publication type:

Article

Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 3017, doi. 10.1111/bph.70022

By:

Gong, Shuaishuai;
Chen, Hong;
Fang, Shuhua;
Li, Mengyu;
Hu, Jingui;
Li, Yue;
Yu, Boyang;
Kou, Junping;
Li, Fang

Publication type:

Article

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2997, doi. 10.1111/bph.70021

By:

Soler‐Cedeño, Omar;
Keegan, Bradley M.;
Alton, Hannah;
Bi, Guo‐Hua;
Linz, Emily;
Vogt, Caleb D.;
Gogarnoiu, Emma S.;
Shi, Lei;
Newman, Amy Hauck;
Xi, Zheng‐Xiong

Publication type:

Article

Time‐varying compartmental models capture hours‐scale variation in the elimination kinetics of vancomycin in rats.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2986, doi. 10.1111/bph.70020

By:

McDonough, Matthew H.;
Gerson, Julian;
Kippin, Tod;
Meiring, Wendy;
Plaxco, Kevin W.

Publication type:

Article

High‐throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin‐deficient limb girdle muscular dystrophy.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2930, doi. 10.1111/bph.70017

By:

Bruge, Celine;
Bourg, Nathalie;
Pellier, Emilie;
Tournois, Johana;
Polentes, Jerome;
Benabides, Manon;
Grossi, Noella;
Bigot, Anne;
Brureau, Anthony;
Richard, Isabelle;
Nissan, Xavier

Publication type:

Article

Sub‐chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2914, doi. 10.1111/bph.70015

By:

Bergadà‐Martínez, Araceli;
de los Reyes‐Ramírez, Lucía;
Martínez‐Torres, Sara;
Ciaran‐Alfano, Laura;
Martínez‐Gallego, Irene;
Maldonado, Rafael;
Rodríguez‐Moreno, Antonio;
Ozaita, Andrés

Publication type:

Article

Drug‐likeness evaluation and inhibitory mechanism of the emodin derivative on cardiac fibrosis based on metastasis‐associated protein 3.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2878, doi. 10.1111/bph.70012

By:

Liu, Heng;
Li, Runze;
Wang, Zhixia;
Han, Weina;
Sun, Xiuxiu;
Dong, Xinxin;
Lou, Han;
Xu, Run;
Hu, Ange;
Baranenko, Denis;
Bai, Xue;
Xiao, Dan;
Lu, Weihong

Publication type:

Article

Rescue of loss‐of‐function long QT syndrome‐associated mutations in KV7.1/KCNE1 by the endocannabinoid N‐arachidonoyl‐L‐serine (ARA‐S).

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2861, doi. 10.1111/bph.70008

By:

Hiniesto‐Iñigo, Irene;
Sridhar, Akshay;
Louradour, Julien;
De la Cruz, Alicia;
Lundholm, Siri;
Jauregi‐Miguel, Amaia;
Giannetti, Federica;
Sala, Luca;
Odening, Katja E.;
Larsson, H. Peter;
Ottosson, Nina E.;
Liin, Sara I.

Publication type:

Article

TLR2 activates AP‐1 to facilitate CTGF transcription and stimulate doxorubicin‐induced myocardial injury.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2897, doi. 10.1111/bph.17423

By:

Hong, Lang;
Cai, Xinyong;
Zhan, Yuliang;
Liu, Songtao;
Zou, Pengtao;
Chen, Yanmei;
Shao, Liang

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 13, p. 2823, doi. 10.1111/bph.16454
Publication type:: Article

Works in British Journal of Pharmacology, 2025, Vol 182, Issue 13

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024.

Correction to "Ethosuximide: Subunit‐ and Gβγ‐dependent blocker and reporter of allosteric changes in GIRK channels".

Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics.

Functional MRP1 activity in human skeletal muscle.

C‐model: A comprehensive enhanced pharmacokinetic/pharmacodynamic simulation environment targeting the complement system.

P2Y<sub>14</sub> receptor activation of platelets induces Ca<sup>2+</sup> mobilization and Rho‐GTPase‐dependent motility that requires an interaction with P2Y<sub>1</sub> receptors.

Behavioural and pharmacokinetic analysis of heroin and cocaine self‐administration: Effects of timeout on self‐administration and choice in male rats.

Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator.

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D<sub>3</sub> receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents.

Time‐varying compartmental models capture hours‐scale variation in the elimination kinetics of vancomycin in rats.

High‐throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin‐deficient limb girdle muscular dystrophy.

Sub‐chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice.

Drug‐likeness evaluation and inhibitory mechanism of the emodin derivative on cardiac fibrosis based on metastasis‐associated protein 3.

Rescue of loss‐of‐function long QT syndrome‐associated mutations in K<sub>V</sub>7.1/KCNE1 by the endocannabinoid N‐arachidonoyl‐L‐serine (ARA‐S).

TLR2 activates AP‐1 to facilitate CTGF transcription and stimulate doxorubicin‐induced myocardial injury.

Issue Information.